Primary Department: Purchasing
Primary Department Head/Elected Official: Kimberly J. Williams, JD
Secondary Department: Public Health Services
Secondary Department Head/Elected Official: Leah Barton
Regular or Supplemental RCA: Regular RCA
Type of Request: Financial Authorization
Project ID (if applicable): N/A
Vendor/Entity Legal Name (if applicable): Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; Sanofi Pasteur, Inc.
MWBE Contracted Goal (if applicable): N/A
MWBE Current Participation (if applicable): N/A
Justification for 0% MWBE Participation Goal: N/A - Goal not applicable to request
Grant Indirect Costs Rate (if applicable):
Justification for 0% Grant Indirect Costs Rate (if applicable): Choose an item.
Request Summary (Agenda Caption):
title
Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Pasteur, Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services through September 30, 2026 with additional mutually agreed upon renewal option(s), using grant funds provided by the U.S. Department of Health and Human Services Refugee Medical Assistance Program.
end
Background and Discussion:
The Refugee Health Screening Program is required by the grant to provide various vaccines to incoming
refugees which are purchased through the vendors listed above.
Expected Impact:
The Refugee Health Screening Program (RHSP) of Harris County Public Health (HCPH) provides vaccines along
with various other services to incoming refugees as part of the grant requirement. The HCPH RHSP is the only
refugee program in the Houston area providing such services to incoming refugees.
Alternative Options:
Due to the amount of health services needed by the refugee p...
Click here for full text